Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 10.43
+1.30 (14.24%)
At close: Feb 20, 2026
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 3.09 billion as of February 20, 2026. Its market cap has decreased by -68.30% in one year.
Market Cap
3.09B
Enterprise Value
3.58B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.43
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 3.09B, an increase of 1,934.44%. That is a compound annual growth rate of 43.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 3.09B | -18.48% |
| Dec 31, 2025 | 3.79B | -53.94% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 3.15B |
| Neuren Pharmaceuticals | 1.65B |
| PYC Therapeutics | 1.41B |
| Clarity Pharmaceuticals | 1.26B |
| Opthea | 738.77M |
| Immutep | 567.38M |
| Clinuvel Pharmaceuticals | 553.21M |
| Racura Oncology | 403.01M |